Skip to main content

Opaleye Management Inc.'s Form 4 filing

Protara Therapeutics, Inc. (TARA) · filed Jul 11, 2024

Accession no.
0001493152-24-027028
Filed
Jul 11, 2024
Trade date
Jul 9-11, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions. Open-market sales total $175.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Opaleye Management Inc.CIK 000159585510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 9, 2024Common Stock, par value $0.001 per shareSSaleDisposed−5,997$2.21−$13,253.372,207,477Indirect
Jul 9, 2024Common Stock, par value $0.001 per shareSSaleDisposed−2,500$2.21−$5,52580,000Indirect
Jul 10, 2024Common Stock, par value $0.001 per shareSSaleDisposed−13,061$2.31−$30,170.912,194,416Indirect
Jul 10, 2024Common Stock, par value $0.001 per shareSSaleDisposed−5,000$2.31−$11,55075,000Indirect
Jul 11, 2024Common Stock, par value $0.001 per shareSSaleDisposed−32,993$2.40−$79,183.22,161,423Indirect
Jul 11, 2024Common Stock, par value $0.001 per shareSSaleDisposed−15,000$2.40−$36,00060,000Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)